Global IoT Antenna Shipments to Reach 13 Billion by 2030 Despite Lingering Post-Pandemic Headwinds
NEW YORK, Oct. 30, 2025 /PRNewswire/ — Wordwide IoT antenna shipments are projected to recover to 13 billion units by 2030, according to global technology... Read more.
Lucid Announces Organizational Changes to Accelerate Growth, Optimize Decision-Making and Strengthen Global Expansion
NEWARK, Calif., Nov. 5, 2025 /PRNewswire/ — Lucid Group, Inc. (NASDAQ: LCID), maker of the world’s most advanced electric vehicles, today announced... Read more.
Caris Life Sciences Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
Revenue growth of 113% driven by strong performance in molecular profiling services Raises 2025 revenue guidance to $720 to $730 million, representing year-over-year... Read more.
Resideo Announces Third Quarter 2025 Financial Results
Third quarter net revenue of $1.86 billion, up 2% year-over-year; ADI and Products & Solutions (“P&S”) each grew net revenue 2% year-over-year... Read more.
Tyra Biosciences Reports Third Quarter 2025 Financial Results and Highlights
– Dosed first patients with dabogratinib in BEACH301 and SURF302; interim results from both studies expected in 2026 – – Expanded development of... Read more.
Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025
SAN MATEO, Calif., Nov. 5, 2025 /PRNewswire/ — Talphera, Inc. (Nasdaq: TLPH), (“Talphera”), a specialty pharmaceutical company focused on the development... Read more.
Halozyme Therapeutics, Inc. Announces Proposed Offering of $650 Million of Convertible Senior Notes due 2031 and $650 Million of Convertible Senior Notes due 2032
SAN DIEGO, Nov. 5, 2025 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme” or the “Company”), today announced that... Read more.
PTC ANNOUNCES FOURTH FISCAL QUARTER AND FULL FISCAL YEAR 2025 RESULTS
Posts record annual cash flow; Strategic focus positions company for durable growth Solid execution in FY’25 Constant currency ARR growth of 8.5% Record operating... Read more.
Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program
HEPLISAV-B® quarterly net product revenue of $90 million, a 13% YoY increase; r eiterates full year 2025 HEPLISAV-B® net product revenue guidance range of $315... Read more.
TPG to Acquire PTC’s Industrial Connectivity and IoT Businesses
Sale of Kepware and ThingWorx businesses enables PTC to increase focus on Intelligent Product Lifecycle vision Transaction will provide the Kepware and ThingWorx... Read more.